Western Wealth Management »

Marker Therapeutics shares owned by Western Wealth Management

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $477 368 1.30

More positions owned by Western Wealth Management

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SPYG)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)

View all positions for Western Wealth Management

Top funds holding Marker Therapeutics

NEA Management Company
Blue Owl Capital Holdings
Vanguard Capital Management
Vanguard Group
Aisling Capital Management
Geode Capital Management
Renaissance Technologies
Advisor Group Holdings
Vanguard Fiduciary Trust
LPL Financial
Two Sigma Investments
XTX Topco
Jane Street
UBS Group
Invst

View all funds holding Marker Therapeutics